SLC5A2 and Hyperglycemia: Immunoreaction with anti-SGLT2 was significantly stronger in STZ-administered mice than in healthy mice (Figure 3), suggesting that hyperglycemia increases SGLT-2 expression, as previous studies have indicated (6–9).